Wall Street brokerages expect HCA Healthcare Inc (NYSE:HCA) to post earnings per share of $2.58 for the current quarter, according to Zacks Investment Research. Ten analysts have issued estimates for HCA Healthcare’s earnings, with estimates ranging from $2.46 to $2.68. HCA Healthcare posted earnings per share of $2.12 in the same quarter last year, which indicates a positive year over year growth rate of 21.7%. The business is expected to issue its next quarterly earnings report on Tuesday, January 29th.

According to Zacks, analysts expect that HCA Healthcare will report full year earnings of $9.34 per share for the current financial year, with EPS estimates ranging from $9.23 to $9.38. For the next financial year, analysts forecast that the business will report earnings of $10.11 per share, with EPS estimates ranging from $9.39 to $10.50. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for HCA Healthcare.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 EPS for the quarter, beating the Zacks’ consensus estimate of $1.93 by $0.23. HCA Healthcare had a net margin of 6.82% and a negative return on equity of 73.71%. The company had revenue of $11.45 billion for the quarter, compared to the consensus estimate of $11.29 billion. During the same period in the prior year, the firm posted $1.13 EPS. The company’s quarterly revenue was up 7.1% compared to the same quarter last year.

A number of research analysts recently commented on the stock. Barclays assumed coverage on shares of HCA Healthcare in a research report on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 target price on the stock. Zacks Investment Research downgraded shares of HCA Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, November 20th. Leerink Swann increased their target price on shares of HCA Healthcare from $140.00 to $150.00 and gave the company an “outperform” rating in a research report on Tuesday, September 4th. BMO Capital Markets increased their target price on shares of HCA Healthcare from $145.00 to $155.00 and gave the company a “buy” rating in a research report on Wednesday, September 5th. Finally, Mizuho set a $150.00 target price on shares of HCA Healthcare and gave the company a “buy” rating in a research report on Tuesday, September 4th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of $144.15.

In related news, SVP Deborah M. Reiner sold 723 shares of the stock in a transaction on Monday, November 5th. The shares were sold at an average price of $135.06, for a total transaction of $97,648.38. Following the completion of the sale, the senior vice president now owns 6,184 shares in the company, valued at approximately $835,211.04. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Jane D. Englebright sold 5,081 shares of the stock in a transaction on Friday, November 9th. The stock was sold at an average price of $141.90, for a total transaction of $720,993.90. Following the sale, the senior vice president now owns 16,504 shares of the company’s stock, valued at approximately $2,341,917.60. The disclosure for this sale can be found here. In the last quarter, insiders have sold 16,763 shares of company stock valued at $2,346,147. 2.80% of the stock is owned by company insiders.

A number of large investors have recently modified their holdings of HCA. Eqis Capital Management Inc. acquired a new stake in HCA Healthcare during the 2nd quarter worth $747,000. Massachusetts Financial Services Co. MA lifted its stake in shares of HCA Healthcare by 62.6% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 891,489 shares of the company’s stock worth $91,466,000 after acquiring an additional 343,121 shares during the period. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of HCA Healthcare in the 2nd quarter worth $8,149,000. First Trust Advisors LP lifted its stake in shares of HCA Healthcare by 68.9% in the 2nd quarter. First Trust Advisors LP now owns 336,146 shares of the company’s stock worth $34,489,000 after acquiring an additional 137,129 shares during the period. Finally, IndexIQ Advisors LLC lifted its stake in shares of HCA Healthcare by 49.8% in the 2nd quarter. IndexIQ Advisors LLC now owns 66,763 shares of the company’s stock worth $6,850,000 after acquiring an additional 22,207 shares during the period. Hedge funds and other institutional investors own 69.94% of the company’s stock.

Shares of NYSE:HCA traded down $4.99 during trading hours on Monday, reaching $135.86. The stock had a trading volume of 1,801,284 shares, compared to its average volume of 1,788,475. HCA Healthcare has a 1 year low of $84.13 and a 1 year high of $147.42. The company has a market cap of $48.48 billion, a PE ratio of 20.62, a P/E/G ratio of 1.24 and a beta of 0.52.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 28th. Investors of record on Monday, December 3rd will be paid a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date is Friday, November 30th. HCA Healthcare’s dividend payout ratio is currently 21.24%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: How do candlesticks reflect price movement?

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.